Dr. Alvarnas is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-359-8111Fax+1 626-301-8889
Summary
- I am a hematologist and blood stem cell transplant physician. I serve as the Vice President of Government Affairs because advocacy provides a way to ensure that government policy serves patients effectively and empowers physicians to provide innovative, life-saving care and clinical trials to patients in need. I am interested in the economics of cancer care. I work with employers and health plans to provide more effective cancer care to their employees. I am interested in the creation of more meaningful value-based care models that integrate adequate data complexity and patient-centricity into their constructs.
Education & Training
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology and Medical Oncology, 1992 - 1997
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 1989 - 1992
- University of California San Francisco School of MedicineClass of 1989
- Santa Clara UniversityBS, Biology, 1981 - 1985
Certifications & Licensure
- AZ State Medical License 1997 - 2025
- CA State Medical License 1991 - 2025
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Top Doctor Pasadena Magazine, 2012-2014, 2016-2018
- Timothy F. Beckett, Jr., Award for Excellence in Clinical Teaching Stanford University Medical Center, 1993
- Award for Teaching Excellent as a Member of the House staff Stanford University Medical Center, 1992
- Join now to see all
Clinical Trials
- Autologous Transplant in HIV Patients (BMT CTN 0803) Start of enrollment: 2010 Apr 01
Publications & Presentations
PubMed
- 7 citationsHIV-1 Remission after Allogeneic Hematopoietic-Cell Transplantation.Jana K Dickter, Ahmed Aribi, Angelo A Cardoso, Sara Gianella, Ketevan Gendzekhadze
The New England Journal of Medicine. 2024-02-15 - 1 citationsImmune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang
Frontiers in Immunology. 2021-09-03 - 116 citationsAcute lymphoblastic leukemia, version 2.2021Patrick A. Brown, Bijal D. Shah, Anjali S. Advani, Patricia Aoun, Michael Boyer
Journal of the National Comprehensive Cancer Network. 2021-09-01
Journal Articles
- Reaping the benefits of recent advances for adults with acute lymphoblastic leukemiaBrown PA, Alvarnas JC, J Natl Compr Canc Netw, 7/1/2012
- Acute Lymphoblastic LeukemiaAlvarnas JC, Brown PA, Aoun P, Ballen KK, Bellam N, Blum W, Boyer MW, Carraway HE, Coccia PF, Coutre SE, Cultrera J, Damon LE, Deangelo DJ, Douer D, Frangoul H, Frankf..., J Natl Compr Canc Netw, 7/1/2012
- Implementation of a configurable loboratory information management system for use in cellular process development and manufacturingRussom D, Ahmed A, Gonzalez N, Alvarnas J, Digiusto D, Cytotherapy, 1/1/2011
- Join now to see all
Press Mentions
- Precision, Personalization, and Equity: Key Trends Shaping the Future of Cancer CareSeptember 22nd, 2024
- Cost-Saving Medicare Advantage May Be a Disadvantage for Complex Cancer Surgery PatientsNovember 21st, 2022
- New California Law Targets Inequity in Cancer Care. Some Say It Doesn't Go Far EnoughOctober 28th, 2022
- Join now to see all
Professional Memberships
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: